Free Trial

GSK (GSK) News Today

→ After Conviction, More Bad News for Trump (From Paradigm Press) (Ad)
Free GSK Stock Alerts
$41.21
-0.33 (-0.79%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 7 at 6:21 PM | cnbc.com
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 7 at 6:06 PM | reuters.com
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
June 7 at 2:32 PM | marketbeat.com
GSK plc (NYSE:GSK) Shares Acquired by Morningstar Investment Services LLC
Morningstar Investment Services LLC boosted its stake in shares of GSK plc (NYSE:GSK - Free Report) by 95.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,216,387 shares of the pharmaceutical company's stock after
June 6 at 5:23 PM | investorplace.com
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 5 at 11:53 AM | marketbeat.com
Armistice Capital LLC Has $81.38 Million Stake in GSK plc (NYSE:GSK)
Armistice Capital LLC increased its stake in shares of GSK plc (NYSE:GSK - Free Report) by 670.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,196,000 shares of the pharmaceutical company's stock after acquiring an additional 1,91
June 3, 2024 | marketbeat.com
Nicholas Company Inc. Has $5.98 Million Stock Position in GSK plc (NYSE:GSK)
Nicholas Company Inc. lowered its position in shares of GSK plc (NYSE:GSK - Free Report) by 20.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 161,440 shares of the pharmaceutical company's stock afte
June 3, 2024 | investorplace.com
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
June 3, 2024 | investorplace.com
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
June 3, 2024 | investopedia.com
GSK Stock Dives After Judge Allows Zantac Cancer Lawsuits To Go Forward
June 3, 2024 | marketbeat.com
GSK (NYSE:GSK) Shares Gap Down to $44.77
GSK (NYSE:GSK) Shares Gap Down to $44.77
June 3, 2024 | cnbc.com
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
June 3, 2024 | businesswire.com
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
June 3, 2024 | reuters.com
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
June 2, 2024 | businesswire.com
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
June 2, 2024 | marketbeat.com
Stifel Financial Corp Has $23.62 Million Stock Position in GSK plc (NYSE:GSK)
Stifel Financial Corp reduced its position in GSK plc (NYSE:GSK - Free Report) by 7.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 637,405 shares of the pharmaceutical company's s
June 2, 2024 | reuters.com
GSK blood cancer drug nearly halves risk of death in late-stage trial
June 1, 2024 | marketbeat.com
Letko Brosseau & Associates Inc. Cuts Position in GSK plc (NYSE:GSK)
Letko Brosseau & Associates Inc. trimmed its position in shares of GSK plc (NYSE:GSK - Free Report) by 1.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,179,935 shares of the pharmaceutical com
June 1, 2024 | marketbeat.com
GSK plc (NYSE:GSK) Short Interest Up 17.8% in May
GSK plc (NYSE:GSK - Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 10,590,000 shares, an increase of 17.8% from the April 30th total of 8,990,000 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily volume of 3,200,000 shares, the days-to-cover ratio is presently 3.3 days.
May 31, 2024 | americanbankingnews.com
GSK (NYSE:GSK) Receives New Coverage from Analysts at The Goldman Sachs Group
May 30, 2024 | marketbeat.com
GSK (NYSE:GSK) Now Covered by Analysts at The Goldman Sachs Group
The Goldman Sachs Group began coverage on GSK in a report on Thursday. They issued a "neutral" rating and a $47.00 price objective on the stock.
May 28, 2024 | marketbeat.com
Hsbc Holdings PLC Acquires Shares of 2,495,096 GSK plc (NYSE:GSK)
Hsbc Holdings PLC acquired a new position in shares of GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,495,096 shares of the pharmaceutical company's stock, valued at approximately
May 28, 2024 | seekingalpha.com
GSK plc: Long-Term Cash Cow
May 27, 2024 | stocknews.com
Top 4 Pharma Stocks for Long-Term Value Investors in 2024
May 27, 2024 | marketbeat.com
Dimensional Fund Advisors LP Increases Stock Position in GSK plc (NYSE:GSK)
Dimensional Fund Advisors LP grew its position in GSK plc (NYSE:GSK - Free Report) by 1.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,777,695 shares of the pharmaceutical company's stock after p
May 27, 2024 | marketbeat.com
GSK plc (NYSE:GSK) Given Consensus Recommendation of "Hold" by Analysts
GSK plc (NYSE:GSK - Get Free Report) has earned a consensus rating of "Hold" from the five ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three hav
May 25, 2024 | marketbeat.com
GSK plc (NYSE:GSK) Shares Bought by Primecap Management Co. CA
Primecap Management Co. CA grew its holdings in GSK plc (NYSE:GSK - Free Report) by 0.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,089,370 shares of the pharmaceutical company's
May 24, 2024 | msn.com
GSK wins US personal injury case over Zantac use
May 24, 2024 | marketbeat.com
Q2 2024 EPS Estimates for GSK plc Decreased by Zacks Research (NYSE:GSK)
GSK plc (NYSE:GSK - Free Report) - Investment analysts at Zacks Research cut their Q2 2024 earnings per share estimates for GSK in a research report issued on Wednesday, May 22nd. Zacks Research analyst E. Bagri now expects that the pharmaceutical company will post earnings of $1.00 per share for
May 23, 2024 | marketbeat.com
GSK plc (NYSE:GSK) Shares Purchased by Trexquant Investment LP
Trexquant Investment LP lifted its stake in GSK plc (NYSE:GSK - Free Report) by 1,710.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 121,746 shares of the pharmaceutical company's stock after purchasing an additional 115,022 shares du
May 23, 2024 | marketbeat.com
Zacks Research Weighs in on GSK plc's Q3 2024 Earnings (NYSE:GSK)
GSK plc (NYSE:GSK - Free Report) - Research analysts at Zacks Research upped their Q3 2024 earnings per share (EPS) estimates for GSK in a research note issued to investors on Wednesday, May 22nd. Zacks Research analyst E. Bagri now expects that the pharmaceutical company will earn $1.25 per shar
May 22, 2024 | msn.com
GSK succeeds in late-stage trials for asthma candidate
May 22, 2024 | marketbeat.com
JPL Wealth Management LLC Purchases New Position in GSK plc (NYSE:GSK)
JPL Wealth Management LLC acquired a new position in GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 30,461 shares of the pharmaceutical company's stock, valued at approximately $1
May 22, 2024 | seekingalpha.com
GSK Breathes New Life Into Asthma Treatment With Depemokimab
May 21, 2024 | marketbeat.com
Bard Financial Services Inc. Has $1.52 Million Stock Holdings in GSK plc (NYSE:GSK)
Bard Financial Services Inc. grew its stake in shares of GSK plc (NYSE:GSK - Free Report) by 491.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 41,045 shares of the pharmaceutical company's stock after buying an additional 34,100 sh
May 21, 2024 | finance.yahoo.com
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
May 21, 2024 | reuters.com
GSK's asthma drug shows promise in reducing severe attacks
May 21, 2024 | reuters.com
GSK's asthma drug shows promise in reducing severe attacks
May 20, 2024 | marketbeat.com
Brandes Investment Partners LP Has $39.48 Million Holdings in GSK plc (NYSE:GSK)
Brandes Investment Partners LP lifted its position in GSK plc (NYSE:GSK - Free Report) by 55.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,065,333 shares of the pharmaceutical company's stock afte
May 20, 2024 | finance.yahoo.com
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
May 20, 2024 | reuters.com
GSK faces whistleblower lawsuit over Zantac cancer risk
May 19, 2024 | marketbeat.com
Arjuna Capital Takes $1.16 Million Position in GSK plc (NYSE:GSK)
Arjuna Capital bought a new position in shares of GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 31,253 shares of the pharmaceutical company's stock, valued at approxi
May 18, 2024 | marketbeat.com
GSK plc (NYSE:GSK) is Equity Investment Corp's 5th Largest Position
Equity Investment Corp reduced its position in GSK plc (NYSE:GSK - Free Report) by 1.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,243,259 shares of the pharmaceutical company's stock after sellin
May 17, 2024 | finance.yahoo.com
GSK to divest remaining 4.2% stake in Haleon
May 17, 2024 | msn.com
GSK completes sale of Haleon shares having raised £3.9bn since IPO
May 17, 2024 | bloomberg.com
GSK to Sell Remaining $1.6 Billion Stake in Haleon
May 17, 2024 | thetimes.co.uk
GSK sells remaining stake in Haleon for £1.2bn
May 17, 2024 | msn.com
GSK raises $1.5 billion from sale of remaining Haleon stake
May 17, 2024 | lse.co.uk
LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake
May 17, 2024 | marketwatch.com
GSK Sells Last Haleon Shares for $1.58 Bln
May 17, 2024 | msn.com
GSK raises £1.25bn as it offloads final stake in Haleon
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Breaking - The US Gov. Seized CITGO (Ad)

Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).

Get all the details here.

GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment
▼
0.30

0.72
▲
Average
Medical
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week
▼
17

11
▲
GSK Articles
Average Week

Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:GSK) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Secret energy grid to power millions of homes
This high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type ...
Porter & Company | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI Hell Will Break Loose [June 30, 2024] …
On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...
Banyan Hill Publishing | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...
Colonial Metals | Sponsored